SCHEMBL19904425

SCHEMBL19904425

O=C(NC(Cc1ccc2c(c1)OCCO2)CN1CCCC1)C1CCN(c2ccc(Cl)c(Cl)c2)C1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 5/20 0.45
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 1/20 0.42
PDCD1 Q15116 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
ACACB O00763 7/20 0.39
HTR1A P08908 1/20 0.38
SSTR1 P30872 1/20 0.37
SSTR3 P32745 1/20 0.37
UGCG Q16739 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904464 1.00 NOTUM (0.45) NOTUMUSP2ALDH1A1HPGDTSHR
SCHEMBL19904519 0.94 SMN1; SMN2 (0.41) NOTUMUSP2ALDH1A1HPGDTSHR
SCHEMBL19904652 0.92 KMT2A (0.49) NOTUMUSP2ALDH1A1HPGDTSHR
SCHEMBL19904451 0.92 KMT2A (0.49) NOTUMUSP2ALDH1A1HPGDTSHR
SCHEMBL18101714 0.92 KMT2A (0.49) NOTUMUSP2ALDH1A1HPGDTSHR
SCHEMBL18101715 0.92 KMT2A (0.49) NOTUMUSP2ALDH1A1HPGDTSHR
SCHEMBL18101713 0.92 KMT2A (0.49) NOTUMUSP2ALDH1A1HPGDTSHR
SCHEMBL19904487 0.91 KMT2A (0.48) NOTUMUSP2ALDH1A1HPGDTSHR
SCHEMBL19904430 0.91 KMT2A (0.48) NOTUMUSP2ALDH1A1HPGDTSHR
SCHEMBL19904516 0.91 ACACB (0.40) USP2ALDH1A1HPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed